Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Accenture
Mallinckrodt
Deloitte
Citi

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 8,790,882

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,790,882
Title:Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
Abstract: The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.
Inventor(s): Albitar; Maher (Sugar Land, TX), Keating; Michael J. (Houston, TX), Manshouri; Taghi (Houston, TX)
Assignee: Board of Regents, The University of Texas System (Austin, TX)
Application Number:13/934,940
Patent Claims:see list of patent claims

Details for Patent 8,790,882

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) 2021-09-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,790,882

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 03024993 Mar 27, 2003
World Intellectual Property Organization (WIPO) 03024993 Oct 16, 2003
United States of America 10018638 Jul 10, 2018
United States of America 2003068664 Apr 10, 2003
United States of America 2010221761 Sep 02, 2010
United States of America 2011236994 Sep 29, 2011
United States of America 2012107846 May 03, 2012
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
Accenture
Julphar
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.